Cargando…
Resistance rates of non-albicans Candida infections in Taiwan after the revision of 2012 Clinical and Laboratory Standards Institute breakpoints
PURPOSE: In 2012, the Clinical and Laboratory Standards Institute (CLSI) revised its breakpoints for drugs and species because of the increase in non-albicans Candida infections and their drug resistance. Following global trends, the non-albicans candidemia resistance rate has increased in Taiwan as...
Autores principales: | Hii, Ing-Moi, Liu, Chun-Eng, Lee, Yu-Lin, Liu, Wei-Lun, Wu, Ping-Feng, Hsieh, Min-Han, Ho, Mao-Wang, Chen, Yen-Hsu, Wang, Fu-Der |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338119/ https://www.ncbi.nlm.nih.gov/pubmed/30679913 http://dx.doi.org/10.2147/IDR.S184884 |
Ejemplares similares
-
Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017) -
Impact of Nutritional Assessment on the Clinical Outcomes of Patients with Non-albicans Candidemia: A Multicenter Study
por: Lee, Yi-Chien, et al.
Publicado: (2021) -
Impact of Revised Broad-Spectrum Cephalosporin Clinical and Laboratory Standards Institute Breakpoints on Susceptibility in Enterobacteriaceae Producing AmpC β-Lactamase
por: Park, Ki-Ho, et al.
Publicado: (2017) -
Epidemiology and Prognostic Factors of Non-albicans Candida species Candidemia: A Multicenter Study
por: Lee, Yu-Lin, et al.
Publicado: (2017) -
Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by Escherichia coli or Klebsiella spp.
por: Ku, Nam Su, et al.
Publicado: (2015)